The increasing prevalence of cancer is expected to drive the growth of global Radiation Therapy Quality Assurance Phantoms in the forecast period, 2024-2028.
According to TechSci Research report, “Radiation Therapy Quality Assurance Phantoms Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028” Global Radiation Therapy Quality Assurance Phantoms Market is anticipated to grow at an impressive rate in the forecast period, 2024-2028. This can be ascribed to the increasing demand for phantoms for the treatment of cancer along with the severe prevalence of cancer across the globe. Additionally, increasing demand for better treatment and increasing burden of different types of cancers like head and neck, prostate, and lung cancer especially in the developed countries in North America and Europe is expected to create lucrative opportunities for market growth in coming years. Besides, increasing research and development activities in the healthcare industry is further expected to support market growth. Similarly, the growing demand for tissue equivalent phantoms for the treatment of skin cancer is anticipated to boost the market growth during the forecast period. Also, the growing demand for precise calibration techniques for efficient diagnostic imaging procedures along with advancement in radiation therapy such as image-guided and intensity-modulated radiation therapy will further boost the market growth over the years.
However, the high cost of phantoms along with the lack of skilled professionals slowed down the growth of The Global Radiation Therapy Quality Assurance Phantoms Market in the forecast period. Similarly, high risks and complications associated with radiation treatments may hamper the Radiation Therapy Quality Assurance Phantoms market growth during the forecast period.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on “Radiation Therapy Quality Assurance Phantoms Market“
The global radiation therapy quality assurance phantoms market can be segmented by technology, therapy, application, and by region.
Based on technology, the global radiation therapy quality assurance phantoms market can be segmented into Linear Accelerators, Cobalt-60, High-Dose Radiation, and Low-Dose Radiation. The cobalt-60 segment dominated the market in 2022 and is expected to continue maintaining its dominance throughout the forecast period. This can be ascribed to the increasing demand for high-dose radiation for the diagnosis of cancer and used to control the level of radiation and kill the malignant cells in tumor and cancer treatment. High efficiency and increasing usage of clotrimazole drug for the treatment of acute vulvovaginal candidiasis disease.
Based on therapy, the market can be segmented into Photon Beam Radiation Therapy, Advanced 3-D Conformal Radiation Therapy, Image Guided Radiation Therapy, Intensity-modulated radiation therapy, Volumetric Modulated Arc Therapy, Intraoperative Radiotherapy, Neutron Beam Therapy, and Brachytherapy. The brachytherapy segment is expected to dominate during the forecast period on account of increasing demand for fast treatment of different types of cancers like prostate, head and neck, cervix, and eye cancers and use for depth of penetration, distance, etc. in surgery times.
Major companies operating in the global radiation therapy quality assurance phantoms market are:
- Computerized Imaging Reference Systems, Inc.
- Fluke Biomedical LLC.
- IBA Dosimetry Gmbh.
- Modus Medical Devices Inc.
- PTW Freiburg GmbH.
- Standard Imaging Inc.
- Sun Nuclear Corporation.
- The Phantom Laboratory Inc.
- Gammex Inc.
- Gold Standard Phantoms Limited
UF Radiation Oncology celebrated the unveiling of its 1.5-Tesla MRI-guided linear accelerator, the Elekta Unity, on July 21. The Unity will welcome its first patients at the end of the month. The 1.5-T MR-Linac allows us to visualize changes in the tumor or tumors with each daily treatment precisely delivered.
In October 2020, the Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital and PTW Freiburg GmbH signed an agreement to collaborate on developing an advanced EPID-based dosimetry solution for automated patient-specific quality assurance during radiotherapy treatment.
Customers can also request for 10% free customization on this report.
“North America is expected to dominate in The Global Radiation Therapy Quality Assurance Phantoms Market on account due to increasing the number of major medical technology companies across the region. Furthermore, increasing the usage of radiotherapy units along with a growing focus on the development of novel technologies and systematic radiation therapy for providing better patient care, growing partnerships and collaboration with the gamma knife manufacturers is further contributing to the demand for Radiation Therapy Quality Assurance Phantoms. Besides, the availability of skilled professionals and early adoption of advanced treatments for different types of cancers in the region and the development of more effective methods for error reduction and process analysis such as failure mode for dose mistakes and effect analysis is further expected to create lucrative opportunities for market growth during the forecast period 2028” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“Radiation Therapy Quality Assurance Phantoms Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Technology (Linear Accelerators, Cobalt-60, High-Dose Radiation, Low-Dose Radiation), By Therapy (Photon Beam Radiation Therapy, Advanced 3-D Conformal Radiation Therapy, Image Guided Radiation Therapy, Intensity-modulated radiation therapy, Volumetric Modulated Arc Therapy, Intraoperative Radiotherapy, Neutron Beam Therapy, Brachytherapy), By Application (Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Head, and Neck Cancers, Skin Cancer, Other) and By Region”, has evaluated the future growth potential of global radiation therapy quality assurance phantoms market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision-makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global radiation therapy quality assurance phantoms market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com
